LUNG
LUNG
NASDAQ · Health Care

Pulmonx Corp

$2.86
-0.14 (-4.67%)
As of Nov 14, 10:45 PM ET ·
Financial Highlights (FY 2026)
Revenue
91.43M
Net Income
-54,561,618
Gross Margin
74.2%
Profit Margin
-59.7%
Rev Growth
+19.0%
D/E Ratio
0.69
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.2% 74.2% 64.5% 64.5%
Operating Margin -59.3% -53.4% 14.2% 15.2%
Profit Margin -59.7% -56.7% 13.0% 12.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 91.43M 76.82M 18.36M 19.89M
Gross Profit 67.84M 56.99M 11.85M 12.83M
Operating Income -54,220,835 -40,997,018 2.61M 3.02M
Net Income -54,561,618 -41,254,688 2.39M 2.44M
Gross Margin 74.2% 74.2% 64.5% 64.5%
Operating Margin -59.3% -53.4% 14.2% 15.2%
Profit Margin -59.7% -56.7% 13.0% 12.3%
Rev Growth +19.0% +19.0% -0.5% +20.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 25.33M 25.33M 22.81M 25.99M
Total Equity 36.95M 36.95M 28.06M 25.55M
D/E Ratio 0.69 0.69 0.81 1.02
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -53,155,751 -42,424,568 3.71M 4.15M
Free Cash Flow — — 1.86M 2.73M